BackTyra Biosciences Overview
Tyra Biosciences Inc

Tyra Biosciences Target Price

See Tyra Biosciences's analyst price targets ($49) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$25.73

Average Target Price

$49.0090.4% upside

2 analysts in the last 4 months

High: $56 | Low: $42

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-08Piper SandlerAllison Bratzel$56117.6% upsideOpen
2026-08-05JefferiesMaury Raycroft$4263.2% upsideOpen
2026-04-14GuggenheimBrad Canino$54109.9% upsideOpen
2026-02-17H.C. WainwrightMitchell Kapoor$4574.9% upsideOpen
2026-02-13WedbushRobert Driscoll$53106% upsideOpen
2026-02-03Oppenheimer$5094.3% upsideOpen
2026-01-27Barclays$59129.3% upsideOpen
2026-01-23Piper Sandler$4263.2% upsideOpen
2025-12-16WedbushRobert Driscoll$3743.8% upsideOpen
2025-09-10OppenheimerMatthew Biegler$3639.9% upsideOpen
2024-11-11H.C. WainwrightMitchell Kapoor$3016.6% upsideOpen
2024-10-18Bank of America SecuritiesJason Zemansky$3120.5% upsideOpen
2024-09-19OppenheimerMatt Biegler$3328.3% upsideOpen
2024-08-15Raymond JamesChristopher Raymond$3328.3% upsideOpen
2024-08-08H.C. WainwrightMitchell Kapoor$252.8% downsideOpen
2024-03-20H.C. WainwrightMitchell Kapoor$2310.6% downsideOpen
2023-02-03Oppenheimer$1733.9% downsideOpen

Tyra Biosciences (TYRA) FAQ

Tyra Biosciences posts a target price of $49. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $49 for TYRA means covering analysts, on average, see the stock 90.4% upside of $25.73 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for TYRA's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Tyra Biosciences's other metric pages and overview cover the third.

Judging Tyra Biosciences against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $49 here, then scan peer and history charts to see if the gap is persistent.